Probiotics for diarrhea
Pro Research Analysisby 
Searched over 200M research papers
Probiotics for Diarrhea: Efficacy and Safety
Introduction to Probiotics and Diarrhea
Probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits to the host. They are increasingly being studied for their potential to prevent and treat various types of diarrhea, including antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD).
Probiotics for Antibiotic-Associated Diarrhea (AAD)
Efficacy in Children
Several studies have demonstrated that probiotics can significantly reduce the incidence of AAD in children. A systematic review and meta-analysis of 33 trials involving 6,352 participants found that probiotics reduced the incidence of AAD from 19% in the control group to 8% in the probiotic group, with a number needed to treat for an additional beneficial outcome (NNTB) of 9 . High-dose probiotics (≥ 5 billion CFUs per day) were found to be more effective than lower doses . Specific strains such as Lactobacillus rhamnosus GG and Saccharomyces boulardii are particularly recommended for preventing AAD in children Szajewska2016Mantegazza2017.
Efficacy in Adults
In adults, probiotics have also shown a significant protective effect against AAD. A meta-analysis of 42 studies with 11,305 participants found that co-administration of probiotics with antibiotics reduced the risk of AAD by 37% . High doses of probiotics and certain species, mainly from the Lactobacillus and Bifidobacteria genera, were found to be particularly effective . Another review focusing on outpatients found similar results, with probiotics reducing the incidence of AAD from 17.7% in the control group to 8.0% in the probiotic group .
Probiotics for Clostridium difficile-Associated Diarrhea (CDAD)
Probiotics have also been studied for their role in preventing CDAD, a severe form of diarrhea often associated with antibiotic use. A systematic review and meta-analysis of 31 randomized controlled trials involving 8,672 participants found that probiotics reduced the risk of CDAD by 60% . The incidence of CDAD was 1.5% in the probiotic group compared to 4.0% in the control group, with an NNTB of 42 . The effectiveness was particularly notable in trials with a baseline CDAD risk greater than 5%, where probiotics reduced the risk by 70% .
Probiotics for Acute Infectious Diarrhea
Probiotics have also been shown to be effective in reducing the duration and severity of acute infectious diarrhea. A meta-analysis of 63 studies involving 8,014 participants found that probiotics reduced the mean duration of diarrhea by approximately 25 hours and decreased stool frequency on the second day of intervention . The beneficial effects were observed across various probiotic strains and were consistent in both developed and developing countries .
Safety of Probiotics
The safety profile of probiotics is generally favorable. Most studies report low rates of adverse events, which are typically mild and include symptoms like abdominal cramping, nausea, and flatulence Goldenberg2013Guo2019Blaabjerg2017. However, caution is advised in immunocompromised or severely debilitated patients, as there have been rare reports of serious infections .
Conclusion
Probiotics are effective in preventing and reducing the severity of various types of diarrhea, including AAD and CDAD, in both children and adults. High-dose probiotics and specific strains like Lactobacillus rhamnosus GG and Saccharomyces boulardii are particularly effective. While generally safe, probiotics should be used cautiously in vulnerable populations. Further research is needed to optimize probiotic regimens for different patient groups.
Sources and full results
Most relevant research papers on this topic